Karmanos Recognitions

Michigan Cancer Consortium

Michigan Cancer ConsortiumThe Barbara Ann Karmanos Cancer Institute is a member of the Michigan Cancer Consortium.

The MCC is a statewide, broad-based partnership that strives to include all interested public and private organizations and provides a forum for collaboration to reduce the burden of cancer among the citizens of Michigan by achieving the Consortium's research-based and results-oriented cancer prevention and control priorities. For more information visit the MCC website

Goals of Consortium and its members include:

  • Prevent cancer from occurring
  • Promote early detection of cancer using tests that have been shown to reduce mortality
  • Diagnose and treat all patients using the most effective and appropriate methods
  • Optimize quality of life for every person affected by cancer

The Latest From Karmanos Cancer Institute

News

Cancer Is a Beginning | Karmanos' Brand Campaign Revealed

A cancer diagnosis isn’t an ending; it’s the start of a new journey that can reshape everything. Undergoing treatment can transform values, behavi...

Read More

Barbara Ann Karmanos Cancer Institute & Network named recipient of the American Cancer Society lodging grant for cancer patients receiving treatment

The Barbara Ann Karmanos Cancer Institute was recently awarded a $50,000 lodging grant by the American Cancer Society to help eliminate the financ...

Read More

Hibiscus BioVentures partners with the Barbara Ann Karmanos Cancer Institute to advance translational cancer research

Hibiscus BioVentures , a firm committed to building patient-focused companies around transformative technologies, today announced it has entered i...

Read More
News

CNO Perspectives on Building a Career in Nursing

Listen Now

ACS CAN Michigan Candid Connection, December 2021 — Radhika Gogoi, M.D., Ph.D.

Listen Now

ACS CAN Michigan Candid Connection, August 2021 — April Brown

Listen Now